“fred-hutchinson-cancer-research-center” Archives

in
Entry Author Date Location
Saver Rate Ends Today for Seattle’s Life Science Disruptors 04/26/16 Seattle
West Coast Bio Roundup: Prince, Theranos, Second Genome, CytomX & More 04/22/16 San Francisco
West Coast Biotech Roundup: Alfred Mann, ResMed, Illumina, & More 02/26/16 San Diego
Emphasizing Collaboration at a Pivotal Moment in Cancer Research 02/24/16 San Diego
With SQZ Deal, Roche Finally Dips Its Toes into Cell Therapy 12/07/15 Boston
Presage Nabs Cancer Rx To Test In Its Drug Cocktail Injection System 11/25/15 Seattle
With New Tools, Adaptive Bio Ready To Bolt Together A Drug Business 08/20/15 Seattle
West Coast Biotech Roundup: Hutch, Gilead, Soon-Shiong IPO & More 07/30/15 San Francisco
Welcome To The Sharing Economy. Cancer Researchers Are Next. 06/23/15 National
West Coast Biotech Roundup: Avalanche, CytomX, BioMarin, Dubs & More 06/19/15 San Francisco
Joining The “Big Data Party,” Fred Hutch Hires Broad’s Top Techie 06/16/15 Seattle
West Coast Biotech Roundup: PCSK9, Amgen, SeaGen, Twist, Serenus 06/11/15 Seattle
Innovation and Entrepreneurship in Washington by the Numbers 06/05/15 Seattle
Talking Cure? For Cancer Immunotherapy, Still Many Rivers to Cross 05/12/15 National
Slideshow: Seattle Biotech Seizes the Momentum 05/07/15 Seattle
Adaptive Reels in Whopping $195M For Immuno-Sequencing Work 05/06/15 Seattle
To Find Combos, Presage Debuts Drug-Test Device In Cancer Patients 04/22/15 Seattle
Here’s The Agenda for Seattle Biotech Seizes The Momentum, May 6 04/20/15 Seattle
Academia vs. BioPharma: Young Scientists Between A Rock and A Hard Place 04/06/15 Seattle
West Coast Biotech Roundup: Zymeworks, Lee Hood, Sue Biggins, Nektar 01/22/15 Seattle
Larry Corey, Cofounder of 2014 Top Biotech Juno: “It’s No Outlier” 01/05/15 Seattle
Juno Just Raised A Ton of Cash. Here Comes the Spending Part. 12/19/14 Seattle
With $2B Market Cap and New Shareholder Rules, Juno Ready for Debut 12/18/14 Seattle
West Coast Biotech Roundup: Gilead, Juno, Hutch, Fibrogen & More 11/20/14 Seattle
Seattle’s Fred Hutch Taps a Harvard, Merck Vet As New President 11/20/14 Seattle
Juno, Less Than a Year Old, Lines up IPO to Fund Cancer Work 11/17/14 Seattle
What Early Looks From ASH Tell Us About Cancer Immunotherapy 11/07/14 National
What Seattle Needs (Part 3): Working Together to Revitalize Biotech 10/08/14 Seattle
With $310M and Public Investors Aboard, Is a Juno IPO Next? 08/05/14 Seattle
Hutch Starts Search for New Prez as Corey Steps Down 05/08/14 Seattle
Page 1 of 8 next page »